Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 715 of 715 entries
View as:

A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00170755 Org: User:
Start: 04/30/02 End: 01/31/05 Due: 01/31/06

Efficacy and Safety of BGG492 in the Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT00892203 Org: User:
Start: 04/30/09 End: 08/31/10 Due: 08/31/11

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00331864 Org: User:
Start: 04/30/06 End: 04/30/08 Due: 04/30/09

Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Phase: N/A Priority: Normal
NCT ID: NCT01103024 Org: User:
Start: 12/31/10 End: 02/28/11 Due: 02/28/12

Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00125346 Org: User:
Start: 09/30/05 End: 02/28/07 Due: 02/28/08

A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00411567 Org: User:
Start: 07/31/06 End: - Due: -

Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00558285 Org: User:
Start: 11/30/07 End: 07/31/08 Due: 07/31/09

Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine

Phase: N/A Priority: Normal
NCT ID: NCT00367939 Org: User:
Start: 12/31/05 End: 07/31/06 Due: 07/31/07

Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00238901 Org: User:
Start: 12/31/02 End: - Due: -

Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)

Phase: N/A Priority: Normal
NCT ID: NCT00154271 Org: User:
Start: 01/31/04 End: 06/30/05 Due: 06/30/06

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00171535 Org: User:
Start: 10/31/04 End: 04/30/05 Due: 04/30/06

Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients

Phase: N/A Priority: Normal
NCT ID: NCT00724776 Org: User:
Start: 07/31/08 End: - Due: -

Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance

Phase: N/A Priority: Normal
NCT ID: NCT00237250 Org: User:
Start: 10/31/05 End: 07/31/06 Due: 07/31/07

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Phase: N/A Priority: Normal
NCT ID: NCT00170963 Org: User:
Start: 10/31/04 End: 06/30/05 Due: 06/30/06

Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00284934 Org: User:
Start: 12/31/05 End: 06/30/08 Due: 06/30/09